全文获取类型
收费全文 | 357篇 |
免费 | 39篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 19篇 |
妇产科学 | 8篇 |
基础医学 | 38篇 |
口腔科学 | 3篇 |
临床医学 | 42篇 |
内科学 | 55篇 |
皮肤病学 | 10篇 |
神经病学 | 44篇 |
特种医学 | 62篇 |
外科学 | 41篇 |
综合类 | 11篇 |
预防医学 | 25篇 |
眼科学 | 4篇 |
药学 | 25篇 |
中国医学 | 1篇 |
肿瘤学 | 16篇 |
出版年
2021年 | 4篇 |
2020年 | 3篇 |
2019年 | 11篇 |
2018年 | 11篇 |
2017年 | 10篇 |
2016年 | 5篇 |
2015年 | 11篇 |
2014年 | 8篇 |
2013年 | 17篇 |
2012年 | 7篇 |
2011年 | 8篇 |
2010年 | 12篇 |
2009年 | 15篇 |
2008年 | 6篇 |
2007年 | 16篇 |
2006年 | 16篇 |
2005年 | 14篇 |
2004年 | 6篇 |
2003年 | 6篇 |
2002年 | 11篇 |
2001年 | 16篇 |
2000年 | 10篇 |
1999年 | 9篇 |
1998年 | 19篇 |
1997年 | 18篇 |
1996年 | 11篇 |
1995年 | 7篇 |
1994年 | 9篇 |
1993年 | 10篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 4篇 |
1988年 | 7篇 |
1987年 | 7篇 |
1986年 | 5篇 |
1985年 | 6篇 |
1984年 | 4篇 |
1983年 | 2篇 |
1981年 | 3篇 |
1980年 | 8篇 |
1979年 | 8篇 |
1978年 | 3篇 |
1977年 | 6篇 |
1976年 | 3篇 |
1975年 | 5篇 |
1974年 | 2篇 |
1973年 | 3篇 |
1972年 | 4篇 |
1969年 | 3篇 |
排序方式: 共有405条查询结果,搜索用时 609 毫秒
91.
KW Whittaker MB ChB P Shah BSc FRCOphth D O'Neill MD FRCP 《International journal of clinical practice》1997,51(2):119-120
SUMMARY To assess the feasibility of performing an ophthalmic assessment on elderly inpatients, we examined 48 patients over 75 years of age who were consecutively admitted to an acute elderly-care ward. Difficulties were encountered in 35 patients (73%). By employing simple methods to overcome these problems, useful information was obtained in all cases and the time taken to complete the examination ranged from six to 20 minutes (mean 7.5 minutes). Doctors looking after elderly patients should be encouraged to assess visual function and must not be deterred by anticipated logistical difficulties. 相似文献
92.
Modelling and costing the consequences of using an ACE inhibitor to slow the progression of renal failure in type I diabetic patients 总被引:1,自引:0,他引:1
Hendry BM; Viberti GC; Hummel S; Bagust A; Piercy J 《QJM : monthly journal of the Association of Physicians》1997,90(4):277-282
Antihypertensive drugs slow the progressive decline in renal function seen
in patients with insulin-dependent diabetes and nephropathy. In a recent
study, the ACE inhibitor captopril protected against this deterioration in
renal function. We developed an economic model to analyse the cost impact
of ACE inhibitor treatment on progression to endstage renal failure (ESRF)
in diabetic patients over 4 years. Two scenarios were compared: one
describing the progression of a cohort of 1000 patients receiving 25 mg
captopril three times daily, and the other for an equivalent cohort without
such prophylactic treatment. Previously published data were used to
estimate the transition rates for each stage from the onset of renal
failure until death. All direct costs were discounted by an annual rate of
6%, and were subjected to sensitivity analysis. The discounted cost saving
of ACE inhibitor treatment for a cohort of 1000 patients was estimated as
0.95 million pounds over 4 years. Under sensitivity analysis, these results
were very robust to variations in the costs of ESRF treatment. Prophylactic
treatment with ACE inhibitors was predicted to provide substantial
increases in life expectancy and reduction in the incidence of ESRF, while
also providing significant economic savings.
相似文献
93.
Gribben JG; Neuberg D; Barber M; Moore J; Pesek KW; Freedman AS; Nadler LM 《Blood》1994,83(12):3800-3807
Polymerase chain reaction (PCR) amplification of the t(14;18) has been shown to be a highly sensitive method to detect minimal residual disease in patients with non-Hodgkin's lymphoma (NHL) whose tumors bear this translocation. The ideal tissue source to detect residual lymphoma would be from a previously involved lymph node. However, lymphoid tissue is rarely available once patients achieve complete remission. Although PCR amplification has been used to detect residual lymphoma cells in both bone marrow (BM) and peripheral blood (PB) of patients in complete remission, it is presently unknown whether BM and PB are equivalent tissue sources to detect residual disease. In the present study, we compared the clinical utility of the detection of residual lymphoma in both the BM and the PB of patients with advanced-stage non- Hodgkin's lymphoma before, at the time of, and after high-dose therapy and autologous BM transplantation (ABMT). The detection of residual lymphoma in either the BM or PB was associated with decreased disease- free survival. However, in the present study, 44% of patients who relapsed had no evidence of circulating lymphoma cells in their PB. At the time of BM harvest, PCR-detectable residual lymphoma cells were detected in 211 of 212 patients; although, in a subset of these patients analyzed, lymphoma cells were detected in the peripheral blood of only 49% of patients. When residual lymphoma cells within the autologous BM are infused into the patient these cells are rapidly detectable circulating in the PB in the patient. These cells continue to circulate during the immediate posttransplant period and be detectable in the PB in the majority of patients who are infused with marrow containing residual lymphoma. We conclude that BM is a more informative tissue source than PB in detecting minimal residual disease at the time of and after ABMT, and that contamination of PB early after ABMT appears to be the consequence of reinfusion of lymphoma cells within autologous marrow. 相似文献
94.
Valerie Piercy C.D.Nigel Toseland Nicholas C. Turner 《Metabolism: clinical and experimental》1998,47(12):1477-1480
Prolonged hyperglycemia in type II diabetic patients is linked both with diabetic complications and with further impairment of glucose homeostasis, possibly due to glucose toxicity of the β cell. While the connection between the accumulation of extracellular advanced glycation end products (AGEs) and the development of complications is well established, it has only recently been suggested that intracellular glycation may be equally adverse and could be involved in the pathogenesis of glucose toxicity in vitro. Aminoguanidine is a recognized inhibitor of the formation of both extracellular and intracellular AGEs. In this study, we show that the development of diabetes, measured by increased water intake and concomitant midday blood glucose levels in type II genetically diabetic mice, is reduced by treatment with aminoguanidine at a dosage of 500 mg/kg/d for 12 weeks in the diet. In addition, at the end of the study, aminoguanidine reduced the decline in serum and pancreatic insulin levels and the degree of pancreatic islet morphological degeneration, all of which are associated with pancreatic insufficiency following prolonged hyperglycemia in this animal model. These results suggest that AGEs may be involved in the aggravation of type II diabetes in vivo and aminoguanidine may be beneficial in its treatment. 相似文献
95.
A 43-year-old male with a phenotypically homogeneous, expanded subset of T cells presented in 1981 with anemia and neutropenia. The surface antigen phenotype of 99% of the peripheral blood lymphocytes was T3+, T8+, T4-, and they were morphologically large granular lymphocytes (LGL). The same cells comprised 37% of the marrow nucleated cells. Eight months after he presented, the peripheral blood T8+, LGL diminished spontaneously, and the anemia and neutropenia completely resolved. The patient remains hematologically normal as of October 1984. To determine if the T8+, LGL represented a clonal expansion, DNA from peripheral blood lymphocytes collected and cryopreserved when the patient was neutropenic and anemic, and when he was hematologically normal, was analyzed for clonal T-cell antigen receptor gene rearrangements. Using Southern blot analysis, a clonal DNA rearrangement was demonstrated, and this clone diminished but was still demonstrable in peripheral blood lymphocytes collected in 1984. The above observations implicate the expanded T8+, LGL in the pathogenesis of the neutropenia and anemia, yet the exact mechanism remains to be elucidated. 相似文献
96.
Gribben JG; Neuberg D; Freedman AS; Gimmi CD; Pesek KW; Barber M; Saporito L; Woo SD; Coral F; Spector N 《Blood》1993,81(12):3449-3457
Although molecular biologic techniques can now detect minimal numbers of residual cancer cells in patients in complete clinical remission, the clinical significance of minimal residual disease has never been conclusively established. If the detection of minimal residual disease predicts which patients will relapse, then therapy could be altered based upon the detection of these cells. The t(14;18) can be detected by polymerase chain reaction (PCR) amplification in 50% of patients with B-cell non-Hodgkin's lymphoma and allows detection of one lymphoma cell in up to 1 million normal cells. To determine the clinical significance of the detection of minimal residual lymphoma cells in the bone marrow (BM) PCR amplification was used to detect the presence of residual lymphoma cells after autologous BM transplantation (ABMT) in serial BM samples from 134 patients with B-cell lymphoma in whom a bcl- 2 translocation could be detected. PCR analysis was performed on a total of 542 BM samples obtained while these patients were in complete remission. Disease-free survival was markedly increased in patients with no PCR-detectable lymphoma cells in the marrow compared with those in whom residual lymphoma cells were detected (P < .00001), and the presence of detectable lymphoma cells was associated with a 48-fold increase in the risk of relapse. Of the 77 patients (57%) with no PCR- detectable lymphoma cells in their most recent BM sample, none have relapsed. In contrast, all 33 patients (25%) who have relapsed had PCR- detectable lymphoma cells detected in their BM before clinical relapse occurred. In 19 patients (14%), residual lymphoma cells in the BM were detected early following transplantation and subsequently were no longer detectable, although these patients received no further therapy. In these patients, residual lymphoma cells may already have been irreversibly damaged by the high-dose therapy or an endogenous immune mechanism may be capable of eliminating residual lymphoma cells in some patients. Therefore, although the detection of minimal residual disease by PCR following ABMT in patients with lymphoma identifies those patients at high risk of relapse, the presence of residual minimal disease early after transplantation may not be associated with poor prognosis in a small subset of patients. Confirmatory studies will be required to determine more definitively the role of minimal disease detection to identify which patients require additional therapy. 相似文献
97.
Effects of Functional Electrical Stimulation on Denervated Laryngeal Muscle in a Large Animal Model
下载免费PDF全文
![点击此处可从《Artificial organs》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Jon Cheetham Justin D. Perkins Jonathan C. Jarvis Marta Cercone Martin Maw John W. Hermanson Lisa M. Mitchell Richard J. Piercy Norm G. Ducharme 《Artificial organs》2015,39(10):876-885
Bilateral vocal fold paralysis (BVCP) is a life‐threatening condition that follows injury to the Recurrent Laryngeal nerve (RLn) and denervation of the intrinsic laryngeal musculature. Functional electrical stimulation (FES) enables restoration and control of a wide variety of motor functions impaired by lower motor neuron lesions. Here we evaluate the effects of FES on the sole arytenoid abductor, the posterior cricoarytenoid (PCA) muscle in a large animal model of RLn injury. Ten horses were instrumented with two quadripolar intramuscular electrodes in the left PCA muscle. Following a 12‐week denervation period, the PCA was stimulated using a once‐daily training session for 8 weeks in seven animals. Three animals were used as unstimulated controls. Denervation produced a significant increase in rheobase (P < 0.001). Electrical stimulation produced a 30% increase in fiber diameter in comparison with the unstimulated control group (33.9 ± 2.6 µm FES+, 23.6 ± 4.2 µm FES?, P = 0.04). A trend toward a decrease in the proportion of type 1 (slow) fibers and an increase in type 2a (fast) fibers was also observed. Despite these changes, improvement in PCA function at rest was not observed. These data suggest that electrical stimulation using a relatively conservative set of stimulation parameters can reverse the muscle fiber atrophy produced by complete denervation while avoiding a shift to a slow (type 1) fiber type. 相似文献
98.
99.
The Fife hormone service for prostate cancer patients: a cost‐effective and patient‐centric model
下载免费PDF全文
![点击此处可从《International Journal of Urological Nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Lesley C Frew RGN BN Steve KW Leung MB ChB MD FRCSEd 《International Journal of Urological Nursing》2015,9(2):114-118
Injectable hormone therapy is a key element of treatment for many patients with prostate cancer. In the UK, it is typically administered in primary care. In 2003, National Health Service (NHS) Fife rolled out an innovative service for these patients, in which responsibility was moved from primary care to a specialist nurse‐led service in secondary care. The initial rationale was based on cost savings, but a significant number of other advantages have subsequently been demonstrated. These include a simpler patient journey, improved continuity of care and reduced use of consultant time. Standards of care have also improved, with fewer missed appointments, better provision of patient support and rapid access to specialist physician care when needed. An audit of 377 of 542 patients currently treated within the service has provided supportive evidence for many of these advantages. The Fife service offers a cost‐effective model for locally provided nurse‐led care that could be applied to hormone therapy services for prostate cancer elsewhere in the UK, and to services for other cancers with large numbers of patients requiring long‐term management. 相似文献
100.
Evaluation of E-rosetting human lymphocytes with OKT11 and other monoclonal antibodies 总被引:2,自引:0,他引:2
Ip SH; Rittershaus CW; Struzziero CC; Hoxie JA; Hoffman RA; Healey KW; Lifter J 《Blood》1982,60(3):795-799
Monoclonal antibody OKT11 was found to compete with sheep red blood cells for binding sites on human lymphocytes. Preincubation of lymphocytes with OKT11 eliminated E-rosette formation. In a study of 142 peripheral blood samples ranging from 1% to over 90% E-rosette- positive cells, comparison to the percent OKT11-positive cells yielded a correlation coefficient of 0.93. In normal donors, subsets of OKT11+ cells were identified using two-color immunofluorescent staining methods with OKT3, OKT4, and OKT8. On the average, approximately 13% of OKT11+ lymphocytes were OKT3- and 13% of OKT11+ lymphocytes were OKT4- and OKT8-. Based on our double antibody fluorescence intensity data, low antigen density OKT11+ lymphocytes were OKT3-. OKT4+ and OKT8+ lymphocytes in normal peripheral lymphocytes have similar OKT11 antigen density. 相似文献